OLIVIA KULIG-KORT: Open Payments
NPI 1861846982 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 27 payments from 15 companies in 2025. Trend: 2023 $413 · 2024 $2,027 · 2025 $1,886
Food & beverage: $1,886
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $358 |
| Alnylam Pharmaceuticals Inc. | 2 | $248 |
| Siemens Medical Solutions USA, Inc. | 2 | $198 |
| Stryker Corporation | 5 | $181 |
| AngioDynamics, Inc. | 2 | $155 |
| BeOne Medicines USA, Inc. | 1 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Alexion Pharmaceuticals, Inc. | 1 | $120 |
| Bard Peripheral Vascular, Inc. | 3 | $71 |
Products named: RYBREVANT, GIVLAARI, IntelliBlate Microwave Ablation System Console, ALPHAVAC, BRUKINSA, XIFAXAN, DATROWAY, ULTOMIRIS.
Industry payments across CA — which companies pay providers there.
